+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Patient Blood Management Market Research Report by Product (Accessories, Instrument, and Reagent & Kit), Component, End User, Region - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - Global Forecast 2023-2030

  • PDF Icon

    Report

  • 233 Pages
  • January 2023
  • Region: Global
  • 360iResearch™
  • ID: 5134244
UP TO OFF until Mar 31st 2023
The Global Patient Blood Management Market size was estimated at USD 14.70 billion in 2022, USD 15.85 billion in 2023, and is projected to grow at a CAGR of 7.98% to reach USD 27.17 billion by 2030.

Cumulative Impact of COVID-19:

COVID-19 is an unprecedented global public health emergency that affected almost every industry, and the long-term impacts are projected to reflect on the growth of various end-use industries during the forecast period. This ongoing research amplifies the research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19, considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The dedicated section in the report uncovers a detailed analysis of the impact of COVID-19 and its subsequent variant outbreaks on demand, supply, price, and vendor uptake and provides recommendations for sustainable outcomes. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the Global Patient Blood Management Market.

Cumulative Impact of Russia-Ukraine Conflict:

The publisher continuously monitors and update reports considering unceasing political and economic uncertainty due to the Russia-Ukraine Conflict. Negative impacts are globally foreseen, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected people’s lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on Ukraine and reverberate harsh long-term effects on Russia. The report uncovers the implications for demand-supply balances, pressure on pricing variants, impact on import/export and trading, and short-term recommendations to the Global Patient Blood Management Market considering the current update on the conflict and its global responses.

Cumulative Impact of High Inflation:

The high inflation in developed economies globally has resulted in an overall price surge over the past two years. The cumulatively eroding overall purchasing power is expected to impact developing economies significantly and is considered helpful in numerous ways. The report uncovers the effect of high inflation on the long-term performance of the global economy and provides details on fiscal policies measuring and reducing its short-term impacts on demand/supply, cash flow, and currency exchange. The Global Patient Blood Management Market report delivers the high inflation expectation considering the related impact from cost-push and demand-pull inflation.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make better decisions. In this report, the years 2018 and 2021 are considered as historical years, 2022 as the base year, 2023 as the estimated year, and years from 2024 to 2030 are considered as the forecast period.

Market Segmentation & Coverage:

The report on the Global Patient Blood Management Market identifies key attributes about the customer to define the potential market and identify different needs across the industry. Understanding the potential customer group's economies and geographies can help gain business acumen for better strategic decision-making. The market coverage across different industry verticals reveals the hidden truth about the players' strategies in different verticals and helps the organization decide target audience. This report gives you the composite view of sub-markets coupled with comprehensive industry coverage and provides you with the right way of accounting factors such as norms & regulations, culture, to make right coverage strategy for the market plan. This research report categorizes the Global Patient Blood Management Market in order to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market is studied across Accessories, Instrument, Reagent & Kit, and Software. The Accessories is further studied across Blood Bag, Syringe & Needle, and Vial & Tube. The Instrument is further studied across Blood Culture Screening Device, Blood Processing Device, Blood Storage Device, Blood Transfusion Device, and Diagnostic & Testing Instrument. The Blood Culture Screening Device is further studied across Automated Blood Culture System and Supporting Laboratory Equipment. The Blood Processing Device is further studied across Blood Cell Processor and Centrifuges. The Blood Storage Device is further studied across Medical Freezer and Medical Refrigerator. The Blood Transfusion Device is further studied across Apheresis Machine, Cell Salvage System, and Plasma & Plasma Component Separator. The Diagnostic & Testing Instrument is further studied across Blood Grouping Analyzer, Hematology Analyzer, NGS Platform, and PCR Instrument. The Reagent & Kit is further studied across Assay Kit, Blood Culture Media, Blood Typing Reagent, and Slide Staining Reagent. The Software is further studied across Blood Bank Management Software and Transfusion Management Software.
  • Based on Component, the market is studied across Plasma and Whole Blood & Red Blood Cell.
  • Based on End User, the market is studied across Blood Bank, Diagnostic Clinic & Pathology Lab, and Hospital.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes vendors in the Global Patient Blood Management Market. based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) and placed into four quadrants (F: Forefront, P: Pathfinder, N: Niche, and V: Vital). The Global Patient Blood Management Market FPNV Positioning Matrix representation/visualization further aids businesses in better decision-making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market, providing the idea of revenue generation into the overall market compared to other vendors in the space. This provides insights on vendors performance in terms of revenue generation and customer base compared to others. The Global Patient Blood Management Market Share Analysis offers an idea of the size and competitiveness of the vendors for the base year. The outcome reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various strategies for business growth adopted by the vendors. The news in this section covers valuable insights at various stages while keeping up with the business and engaging stakeholders in the economic debate. The Global Patient Blood Management Market Competitive Scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected helps vendors understand the gaps in the marketplace and competitor’s strengths and weaknesses, providing insights to enhance products and services.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Patient Blood Management Market, including Abbott Laboratories, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Bio-Rad Laboratories, Inc., Biomérieux SA, Danaher Corporation, F. Hoffmann-La Roche LTD., Fresenius Se & Co. KGaA, Grifols, S.A., Haemonetics Corporation, Immucor, Inc., LivaNova, Inc., Macopharma, Inc., Merck & Co., Inc., and Terumo Corporation.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Patient Blood Management Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Patient Blood Management Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Patient Blood Management Market?
4. What is the competitive strategic window for opportunities in the Global Patient Blood Management Market?
5. What are the technology trends and regulatory frameworks in the Global Patient Blood Management Market?
6. What is the market share of the leading vendors in the Global Patient Blood Management Market?
7. What modes and strategic moves are considered suitable for entering the Global Patient Blood Management Market?
Frequently Asked Questions about the Global Patient Blood Management Market

What is the estimated value of the Global Patient Blood Management Market?

The Global Patient Blood Management Market was estimated to be valued at $14.7 Billion in 2022.

What is the growth rate of the Global Patient Blood Management Market?

The growth rate of the Global Patient Blood Management Market is 7.9%, with an estimated value of $27.17 Billion by 2030.

What is the forecasted size of the Global Patient Blood Management Market?

The Global Patient Blood Management Market is estimated to be worth $27.17 Billion by 2030.

Who are the key companies in the Global Patient Blood Management Market?

Key companies in the Global Patient Blood Management Market include Abbott Laboratories, Asahi Kasei Medical Co. Ltd., B. Braun Melsungen AG, Bio, Rad Laboratories, Inc., Biomérieux SA, Danaher Corporation, F. Hoffmann and Fresenius Se & Co. KGaA.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Need of blood management due to rising incidences of road accidents with the surge in the prevalence of blood disorders
5.1.1.2. Availability of various patient blood management guidelines
5.1.1.3. Government initiatives encouraging blood donations
5.1.2. Restraints
5.1.2.1. High cost of the automated systems
5.1.3. Opportunities
5.1.3.1. Technology advancements in the patient blood management
5.1.3.2. Development of advanced blood storage and blood transfusion devices
5.1.4. Challenges
5.1.4.1. Shortage of medical professionals
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of Russia-Ukraine Conflict
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Threat of Substitutes
5.5.4. Threat of Substitutes
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
5.8. Client Customization
6. Patient Blood Management Market, by Product
6.1. Introduction
6.2. Accessories
6.3.1. Blood Bag
6.3.2. Syringe & Needle
6.3.3. Vial & Tube
6.3. Instrument
6.4.1. Blood Culture Screening Device
6.4.2.1. Automated Blood Culture System
6.4.2.2. Supporting Laboratory Equipment
6.4.2. Blood Processing Device
6.4.3.1. Blood Cell Processor
6.4.3.2. Centrifuges
6.4.3. Blood Storage Device
6.4.4.1. Medical Freezer
6.4.4.2. Medical Refrigerator
6.4.4. Blood Transfusion Device
6.4.5.1. Apheresis Machine
6.4.5.2. Cell Salvage System
6.4.5.3. Plasma & Plasma Component Separator
6.4.5. Diagnostic & Testing Instrument
6.4.6.1. Blood Grouping Analyzer
6.4.6.2. Hematology Analyzer
6.4.6.3. NGS Platform
6.4.6.4. PCR Instrument
6.4. Reagent & Kit
6.5.1. Assay Kit
6.5.2. Blood Culture Media
6.5.3. Blood Typing Reagent
6.5.4. Slide Staining Reagent
6.5. Software
6.6.1. Blood Bank Management Software
6.6.2. Transfusion Management Software
7. Patient Blood Management Market, by Component
7.1. Introduction
7.2. Plasma
7.3. Whole Blood & Red Blood Cell
8. Patient Blood Management Market, by End User
8.1. Introduction
8.2. Blood Bank
8.3. Diagnostic Clinic & Pathology Lab
8.4. Hospital
9. Americas Patient Blood Management Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Patient Blood Management Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Patient Blood Management Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Product Portfolio Analysis, By Key Player
12.5. Competitive Scenario
12.5.1. Merger & Acquisition
12.5.2. Agreement, Collaboration, & Partnership
12.5.3. New Product Launch & Enhancement
12.5.4. Investment & Funding
12.5.5. Award, Recognition, & Expansion
13. Company Usability Profiles
13.1. Abbott Laboratories
13.2. Asahi Kasei Medical Co. Ltd.
13.3. B. Braun Melsungen AG
13.4. Bio-Rad Laboratories, Inc.
13.5. Biomérieux SA
13.6. Danaher Corporation
13.7. F. Hoffmann-La Roche LTD.
13.8. Fresenius Se & Co. KGaA
13.9. Grifols, S.A.
13.10. Haemonetics Corporation
13.11. Immucor, Inc.
13.12. LivaNova, Inc.
13.13. Macopharma, Inc.
13.14. Merck & Co., Inc.
13.15. Terumo Corporation
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL PATIENT BLOOD MANAGEMENT MARKET: RESEARCH PROCESS
FIGURE 2. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2022 VS 2030
FIGURE 3. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 4. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 6. GLOBAL PATIENT BLOOD MANAGEMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY REGION, 2030
FIGURE 7. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 8. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 9. GLOBAL PATIENT BLOOD MANAGEMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 10. GLOBAL PATIENT BLOOD MANAGEMENT MARKET DYNAMICS
FIGURE 11. GLOBAL PATIENT BLOOD MANAGEMENT MARKET PORTER’S FIVE FORCES ANALYSIS
FIGURE 12. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 13. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 14. GLOBAL PATIENT BLOOD MANAGEMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY PRODUCT, 2030
FIGURE 15. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD BILLION)
FIGURE 16. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BAG, 2018-2030 (USD BILLION)
FIGURE 17. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SYRINGE & NEEDLE, 2018-2030 (USD BILLION)
FIGURE 18. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY VIAL & TUBE, 2018-2030 (USD BILLION)
FIGURE 19. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD BILLION)
FIGURE 20. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD BILLION)
FIGURE 21. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY AUTOMATED BLOOD CULTURE SYSTEM, 2018-2030 (USD BILLION)
FIGURE 22. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SUPPORTING LABORATORY EQUIPMENT, 2018-2030 (USD BILLION)
FIGURE 23. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD BILLION)
FIGURE 24. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CELL PROCESSOR, 2018-2030 (USD BILLION)
FIGURE 25. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CENTRIFUGES, 2018-2030 (USD BILLION)
FIGURE 26. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD BILLION)
FIGURE 27. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY MEDICAL FREEZER, 2018-2030 (USD BILLION)
FIGURE 28. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY MEDICAL REFRIGERATOR, 2018-2030 (USD BILLION)
FIGURE 29. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD BILLION)
FIGURE 30. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APHERESIS MACHINE, 2018-2030 (USD BILLION)
FIGURE 31. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CELL SALVAGE SYSTEM, 2018-2030 (USD BILLION)
FIGURE 32. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PLASMA & PLASMA COMPONENT SEPARATOR, 2018-2030 (USD BILLION)
FIGURE 33. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD BILLION)
FIGURE 34. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD GROUPING ANALYZER, 2018-2030 (USD BILLION)
FIGURE 35. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMATOLOGY ANALYZER, 2018-2030 (USD BILLION)
FIGURE 36. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY NGS PLATFORM, 2018-2030 (USD BILLION)
FIGURE 37. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PCR INSTRUMENT, 2018-2030 (USD BILLION)
FIGURE 38. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD BILLION)
FIGURE 39. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ASSAY KIT, 2018-2030 (USD BILLION)
FIGURE 40. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE MEDIA, 2018-2030 (USD BILLION)
FIGURE 41. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TYPING REAGENT, 2018-2030 (USD BILLION)
FIGURE 42. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SLIDE STAINING REAGENT, 2018-2030 (USD BILLION)
FIGURE 43. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD BILLION)
FIGURE 44. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BANK MANAGEMENT SOFTWARE, 2018-2030 (USD BILLION)
FIGURE 45. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY TRANSFUSION MANAGEMENT SOFTWARE, 2018-2030 (USD BILLION)
FIGURE 46. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2022 VS 2030 (%)
FIGURE 47. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 48. GLOBAL PATIENT BLOOD MANAGEMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COMPONENT, 2030
FIGURE 49. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PLASMA, 2018-2030 (USD BILLION)
FIGURE 50. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY WHOLE BLOOD & RED BLOOD CELL, 2018-2030 (USD BILLION)
FIGURE 51. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2022 VS 2030 (%)
FIGURE 52. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 53. GLOBAL PATIENT BLOOD MANAGEMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY END USER, 2030
FIGURE 54. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BANK, 2018-2030 (USD BILLION)
FIGURE 55. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CLINIC & PATHOLOGY LAB, 2018-2030 (USD BILLION)
FIGURE 56. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD BILLION)
FIGURE 57. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 58. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 59. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 60. AMERICAS PATIENT BLOOD MANAGEMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 61. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 62. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 63. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 64. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 65. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 66. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 67. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 68. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY STATE, 2030
FIGURE 69. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 70. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 71. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 72. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 73. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 74. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 75. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 76. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 77. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 78. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 79. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 80. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 81. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 82. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 83. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 84. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 85. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 86. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 87. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 88. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET COMPETITIVE STRATEGIC WINDOW, BY COUNTRY, 2030
FIGURE 89. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 90. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 91. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 92. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 93. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 94. ISRAEL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 95. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 96. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 97. NIGERIA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 98. NORWAY PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 99. POLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 100. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 101. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 102. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 103. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 104. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 105. SWEDEN PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 106. SWITZERLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 107. TURKEY PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 108. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 109. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 110. GLOBAL PATIENT BLOOD MANAGEMENT MARKET: FPNV POSITIONING MATRIX, 2022
FIGURE 111. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2022
FIGURE 112. GLOBAL PATIENT BLOOD MANAGEMENT MARKET COMPETITIVE SCENARIO, BY KEY TYPE, 2022
List of Tables
TABLE 1. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 4. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REGION, 2018-2030 (USD BILLION)
TABLE 5. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 6. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 7. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, 2018-2030 (USD BILLION)
TABLE 8. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 9. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 10. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BAG, 2018-2030 (USD BILLION)
TABLE 11. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BAG, BY REGION, 2018-2030 (USD BILLION)
TABLE 12. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BAG, BY REGION, 2018-2030 (USD BILLION)
TABLE 13. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SYRINGE & NEEDLE, 2018-2030 (USD BILLION)
TABLE 14. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SYRINGE & NEEDLE, BY REGION, 2018-2030 (USD BILLION)
TABLE 15. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SYRINGE & NEEDLE, BY REGION, 2018-2030 (USD BILLION)
TABLE 16. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY VIAL & TUBE, 2018-2030 (USD BILLION)
TABLE 17. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY VIAL & TUBE, BY REGION, 2018-2030 (USD BILLION)
TABLE 18. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY VIAL & TUBE, BY REGION, 2018-2030 (USD BILLION)
TABLE 19. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, 2018-2030 (USD BILLION)
TABLE 20. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 21. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY INSTRUMENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 22. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, 2018-2030 (USD BILLION)
TABLE 23. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, BY REGION, 2018-2030 (USD BILLION)
TABLE 24. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE SCREENING DEVICE, BY REGION, 2018-2030 (USD BILLION)
TABLE 25. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY AUTOMATED BLOOD CULTURE SYSTEM, 2018-2030 (USD BILLION)
TABLE 26. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY AUTOMATED BLOOD CULTURE SYSTEM, BY REGION, 2018-2030 (USD BILLION)
TABLE 27. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY AUTOMATED BLOOD CULTURE SYSTEM, BY REGION, 2018-2030 (USD BILLION)
TABLE 28. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SUPPORTING LABORATORY EQUIPMENT, 2018-2030 (USD BILLION)
TABLE 29. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SUPPORTING LABORATORY EQUIPMENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 30. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SUPPORTING LABORATORY EQUIPMENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 31. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, 2018-2030 (USD BILLION)
TABLE 32. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, BY REGION, 2018-2030 (USD BILLION)
TABLE 33. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD PROCESSING DEVICE, BY REGION, 2018-2030 (USD BILLION)
TABLE 34. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CELL PROCESSOR, 2018-2030 (USD BILLION)
TABLE 35. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CELL PROCESSOR, BY REGION, 2018-2030 (USD BILLION)
TABLE 36. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CELL PROCESSOR, BY REGION, 2018-2030 (USD BILLION)
TABLE 37. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CENTRIFUGES, 2018-2030 (USD BILLION)
TABLE 38. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD BILLION)
TABLE 39. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CENTRIFUGES, BY REGION, 2018-2030 (USD BILLION)
TABLE 40. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, 2018-2030 (USD BILLION)
TABLE 41. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, BY REGION, 2018-2030 (USD BILLION)
TABLE 42. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD STORAGE DEVICE, BY REGION, 2018-2030 (USD BILLION)
TABLE 43. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY MEDICAL FREEZER, 2018-2030 (USD BILLION)
TABLE 44. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY MEDICAL FREEZER, BY REGION, 2018-2030 (USD BILLION)
TABLE 45. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY MEDICAL FREEZER, BY REGION, 2018-2030 (USD BILLION)
TABLE 46. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY MEDICAL REFRIGERATOR, 2018-2030 (USD BILLION)
TABLE 47. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY MEDICAL REFRIGERATOR, BY REGION, 2018-2030 (USD BILLION)
TABLE 48. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY MEDICAL REFRIGERATOR, BY REGION, 2018-2030 (USD BILLION)
TABLE 49. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, 2018-2030 (USD BILLION)
TABLE 50. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, BY REGION, 2018-2030 (USD BILLION)
TABLE 51. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TRANSFUSION DEVICE, BY REGION, 2018-2030 (USD BILLION)
TABLE 52. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APHERESIS MACHINE, 2018-2030 (USD BILLION)
TABLE 53. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APHERESIS MACHINE, BY REGION, 2018-2030 (USD BILLION)
TABLE 54. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY APHERESIS MACHINE, BY REGION, 2018-2030 (USD BILLION)
TABLE 55. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CELL SALVAGE SYSTEM, 2018-2030 (USD BILLION)
TABLE 56. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CELL SALVAGE SYSTEM, BY REGION, 2018-2030 (USD BILLION)
TABLE 57. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY CELL SALVAGE SYSTEM, BY REGION, 2018-2030 (USD BILLION)
TABLE 58. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PLASMA & PLASMA COMPONENT SEPARATOR, 2018-2030 (USD BILLION)
TABLE 59. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PLASMA & PLASMA COMPONENT SEPARATOR, BY REGION, 2018-2030 (USD BILLION)
TABLE 60. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PLASMA & PLASMA COMPONENT SEPARATOR, BY REGION, 2018-2030 (USD BILLION)
TABLE 61. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, 2018-2030 (USD BILLION)
TABLE 62. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 63. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC & TESTING INSTRUMENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 64. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD GROUPING ANALYZER, 2018-2030 (USD BILLION)
TABLE 65. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD GROUPING ANALYZER, BY REGION, 2018-2030 (USD BILLION)
TABLE 66. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD GROUPING ANALYZER, BY REGION, 2018-2030 (USD BILLION)
TABLE 67. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMATOLOGY ANALYZER, 2018-2030 (USD BILLION)
TABLE 68. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMATOLOGY ANALYZER, BY REGION, 2018-2030 (USD BILLION)
TABLE 69. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HEMATOLOGY ANALYZER, BY REGION, 2018-2030 (USD BILLION)
TABLE 70. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY NGS PLATFORM, 2018-2030 (USD BILLION)
TABLE 71. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY NGS PLATFORM, BY REGION, 2018-2030 (USD BILLION)
TABLE 72. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY NGS PLATFORM, BY REGION, 2018-2030 (USD BILLION)
TABLE 73. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PCR INSTRUMENT, 2018-2030 (USD BILLION)
TABLE 74. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PCR INSTRUMENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 75. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PCR INSTRUMENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 76. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, 2018-2030 (USD BILLION)
TABLE 77. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, BY REGION, 2018-2030 (USD BILLION)
TABLE 78. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY REAGENT & KIT, BY REGION, 2018-2030 (USD BILLION)
TABLE 79. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ASSAY KIT, 2018-2030 (USD BILLION)
TABLE 80. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ASSAY KIT, BY REGION, 2018-2030 (USD BILLION)
TABLE 81. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY ASSAY KIT, BY REGION, 2018-2030 (USD BILLION)
TABLE 82. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE MEDIA, 2018-2030 (USD BILLION)
TABLE 83. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE MEDIA, BY REGION, 2018-2030 (USD BILLION)
TABLE 84. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD CULTURE MEDIA, BY REGION, 2018-2030 (USD BILLION)
TABLE 85. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TYPING REAGENT, 2018-2030 (USD BILLION)
TABLE 86. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TYPING REAGENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 87. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD TYPING REAGENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 88. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SLIDE STAINING REAGENT, 2018-2030 (USD BILLION)
TABLE 89. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SLIDE STAINING REAGENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 90. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SLIDE STAINING REAGENT, BY REGION, 2018-2030 (USD BILLION)
TABLE 91. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, 2018-2030 (USD BILLION)
TABLE 92. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 93. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 94. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BANK MANAGEMENT SOFTWARE, 2018-2030 (USD BILLION)
TABLE 95. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BANK MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 96. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BANK MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 97. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY TRANSFUSION MANAGEMENT SOFTWARE, 2018-2030 (USD BILLION)
TABLE 98. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY TRANSFUSION MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 99. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY TRANSFUSION MANAGEMENT SOFTWARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 100. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 101. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PLASMA, 2018-2030 (USD BILLION)
TABLE 102. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD BILLION)
TABLE 103. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PLASMA, BY REGION, 2018-2030 (USD BILLION)
TABLE 104. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY WHOLE BLOOD & RED BLOOD CELL, 2018-2030 (USD BILLION)
TABLE 105. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY WHOLE BLOOD & RED BLOOD CELL, BY REGION, 2018-2030 (USD BILLION)
TABLE 106. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY WHOLE BLOOD & RED BLOOD CELL, BY REGION, 2018-2030 (USD BILLION)
TABLE 107. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 108. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BANK, 2018-2030 (USD BILLION)
TABLE 109. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2030 (USD BILLION)
TABLE 110. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY BLOOD BANK, BY REGION, 2018-2030 (USD BILLION)
TABLE 111. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CLINIC & PATHOLOGY LAB, 2018-2030 (USD BILLION)
TABLE 112. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CLINIC & PATHOLOGY LAB, BY REGION, 2018-2030 (USD BILLION)
TABLE 113. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY DIAGNOSTIC CLINIC & PATHOLOGY LAB, BY REGION, 2018-2030 (USD BILLION)
TABLE 114. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HOSPITAL, 2018-2030 (USD BILLION)
TABLE 115. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD BILLION)
TABLE 116. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD BILLION)
TABLE 117. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 118. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 119. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 120. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 121. AMERICAS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 122. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 123. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 124. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 125. ARGENTINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 126. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 127. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 128. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 129. BRAZIL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 130. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 131. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 132. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 133. CANADA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 134. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 135. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 136. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 137. MEXICO PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 138. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 139. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY STATE, 2018-2030 (USD BILLION)
TABLE 140. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 141. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 142. UNITED STATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 143. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 144. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 145. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 146. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 147. ASIA-PACIFIC PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 148. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 149. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 150. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 151. AUSTRALIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 152. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 153. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 154. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 155. CHINA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 156. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 157. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 158. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 159. INDIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 160. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 161. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 162. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 163. INDONESIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 164. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 165. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 166. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 167. JAPAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 168. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 169. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 170. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 171. MALAYSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 172. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 173. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 174. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 175. PHILIPPINES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 176. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 177. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 178. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 179. SINGAPORE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 180. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 181. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 182. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 183. SOUTH KOREA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 184. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 185. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 186. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 187. TAIWAN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 188. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 189. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 190. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 191. THAILAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 192. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 193. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 194. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 195. VIETNAM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 196. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 197. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 198. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 199. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 200. EUROPE, MIDDLE EAST & AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 201. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 202. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 203. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 204. DENMARK PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 205. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 206. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 207. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 208. EGYPT PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 209. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 210. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 211. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 212. FINLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 213. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 214. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 215. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 216. FRANCE PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 217. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 218. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 219. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 220. GERMANY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 221. ISRAEL PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 222. ISRAEL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 223. ISRAEL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 224. ISRAEL PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 225. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 226. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 227. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 228. ITALY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 229. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 230. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 231. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 232. NETHERLANDS PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 233. NIGERIA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 234. NIGERIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 235. NIGERIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 236. NIGERIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 237. NORWAY PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 238. NORWAY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 239. NORWAY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 240. NORWAY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 241. POLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 242. POLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 243. POLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 244. POLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 245. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 246. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 247. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 248. QATAR PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 249. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 250. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 251. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 252. RUSSIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 253. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 254. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 255. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 256. SAUDI ARABIA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 257. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 258. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 259. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 260. SOUTH AFRICA PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 261. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 262. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 263. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 264. SPAIN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 265. SWEDEN PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 266. SWEDEN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 267. SWEDEN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 268. SWEDEN PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 269. SWITZERLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 270. SWITZERLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 271. SWITZERLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 272. SWITZERLAND PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 273. TURKEY PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 274. TURKEY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 275. TURKEY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 276. TURKEY PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 277. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 278. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 279. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 280. UNITED ARAB EMIRATES PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 281. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 282. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 283. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY COMPONENT, 2018-2030 (USD BILLION)
TABLE 284. UNITED KINGDOM PATIENT BLOOD MANAGEMENT MARKET SIZE, BY END USER, 2018-2030 (USD BILLION)
TABLE 285. GLOBAL PATIENT BLOOD MANAGEMENT MARKET: FPNV POSITIONING MATRIX - SCORES, 2022
TABLE 286. GLOBAL PATIENT BLOOD MANAGEMENT MARKET: FPNV POSITIONING MATRIX - BUSINESS STRATEGY, 2022
TABLE 287. GLOBAL PATIENT BLOOD MANAGEMENT MARKET: FPNV POSITIONING MATRIX - PRODUCT SATISFACTION, 2022
TABLE 288. GLOBAL PATIENT BLOOD MANAGEMENT MARKET RANKING, BY KEY PLAYER, 2022
TABLE 289. GLOBAL PATIENT BLOOD MANAGEMENT MARKET SHARE, BY KEY PLAYER, 2022
TABLE 290. GLOBAL PATIENT BLOOD MANAGEMENT MARKET PRODUCT PORTFOLIO ANALYSIS, BY KEY PLAYER, 2022
TABLE 291. GLOBAL PATIENT BLOOD MANAGEMENT MARKET MERGER & ACQUISITION
TABLE 292. GLOBAL PATIENT BLOOD MANAGEMENT MARKET AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 293. GLOBAL PATIENT BLOOD MANAGEMENT MARKET NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 294. GLOBAL PATIENT BLOOD MANAGEMENT MARKET INVESTMENT & FUNDING
TABLE 295. GLOBAL PATIENT BLOOD MANAGEMENT MARKET AWARD, RECOGNITION, & EXPANSION
TABLE 296. GLOBAL PATIENT BLOOD MANAGEMENT MARKET: LICENSE & PRICING

Companies Mentioned

  • Abbott Laboratories
  • Asahi Kasei Medical Co. Ltd.
  • B. Braun Melsungen AG
  • Bio-Rad Laboratories, Inc.
  • Biomérieux SA
  • Danaher Corporation
  • F. Hoffmann-La Roche LTD.
  • Fresenius Se & Co. KGaA
  • Grifols, S.A.
  • Haemonetics Corporation
  • Immucor, Inc.
  • LivaNova, Inc.
  • Macopharma, Inc.
  • Merck & Co., Inc.
  • Terumo Corporation

Methodology

Loading
LOADING...